sellWeak10b5-1 plan
Craig B Reynolds sold $5.4M of MASI
director at MASIMO CORP. 40,000 shares at an average of $136.17, traded Apr 26, 2024, filed Apr 30, 2024.
Warning score
25Value
$5.4M
40,000 shares
Holdings after
7,406
-84% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +25Trade size$5.4M at market
- +20Share of holdings soldSold 84% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000937556-24-000030, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | MOption exercise Common Stock10b5-1 | +40,000 | $23.04 | $922k | 47,406 | Apr 30, 2024 |
| Apr 26, 2024 | SOpen-market sale Common Stock10b5-1 | -40,000 | $136.17 | $5.4M | 7,406 | Apr 30, 2024 |
| Apr 26, 2024 | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -40,000 | $0.00 | $0 | 10,000 | Apr 30, 2024 |
Related signals
Other insiders at MASIMO CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | MASIMO CORP | Anand Sampath EVP, Ops & Clinical Research | $2.6M 18,680 shares | -31% | |
| 28Weak | MASIMO CORP | Michelle Brennan Interim CEO | $31k 200 shares | +3% | |
| 50Moderate | MASIMO CORP | William R Jellison director | $438k 3,000 shares | +168% | |
| 20Weak | MASIMO CORP | Bilal Muhsin Chief Operating Officer | $1.6M 10,000 shares | -29% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.